Global Molecular Biomarker Market Expected To Register A CAGR Of 5.2% Over 2018-2022

Date: 2018-03-01

A Molecular Biomarker is a biomarker is a measurable indicator of the severity or presence of some disease state. More generally a biomarker is anything that can be used as an indicator of a particular disease state or some other physiological state of an organism.

The consumption of Molecular Biomarker by drug discovery and development is considered as the major driver to the Molecular Biomarker market, also the diagnosis for particularly cancer, cardiovascular diseases and disorders of the central nervous system are also play a major role fueling the growth for Molecular Biomarker, according to research, global Molecular Biomarker market is expected to register a CAGR of 5.2% over 2016-2020.

Base on application, the Molecular Biomarkers play a role in use of pharmacogenetics, pharmacogenomics and pharmacoproteomics for development of personalized medicine. According to research, the proteomics, metabolomics, molecular diagnostics accounted for the largest market in 2017.

Geographically, The EU is predominant of the market thanks to their pharmaceutical giants took colossal investments on drug discovery and development and well established mature market, region followed by North America, which is expected to grow at highest CAGR for the forecast period.

Global top manufacturers operating in Molecular Biomarker market are Abbott Molecular, Cynvenio, Agilent, Epic Sciences, Foundation Medicine, Genomic Health, Molecular Response Corp., Nodality, Qiagen, Roche Molecular Systems among others.

Global Molecular Biomarker market share by geography as following:

Read Full Report:

Joanna | Executive – International Business and partner Relations
E-mail: | Tel: 510-400-8520


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample